foxo4 dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Full article: Targeting Cellular Senescence

References 1.Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C

Sangeeta Agrawal Read full bio of shreeja pillai Read full bio of Rebecca Malachi Read full bio of Dr

Sikiric involved the following authors: Gorana Aralica, Josip Aralica, Gojko Buljat, Valentina Coric, Vedran Coric, Bozidar Duplancic, Miroslav Gjurasin, Zeljko Grabarevic, Miroslav Hanzevacki, Stipislav Jadrijevic, Vjekoslav Jagic, Pasko Konjevoda, Martina Lovric, Anton Marovic, Pavle Miklic, Darko Mikus, Stjepan Mise, Darko Perovic, Marijan Petek, Ivo Rotkvic, Rudolf Rucman, Bozidar Sebecic, Sven Seiwerth, Jadranka Separovic, Zoran Simec, Zoran Slobodnjak, Dinko Stancic-Rokotov, Branko Turkovic, Tomislav Ziger, Ivan Zoricic

Given that spleen is the principal immune organ, it plays a vital in both cellular and humoral immunity

The trend is toward broader, more sensitive screening